AU3812395A - Inducible cell ablation - Google Patents

Inducible cell ablation

Info

Publication number
AU3812395A
AU3812395A AU38123/95A AU3812395A AU3812395A AU 3812395 A AU3812395 A AU 3812395A AU 38123/95 A AU38123/95 A AU 38123/95A AU 3812395 A AU3812395 A AU 3812395A AU 3812395 A AU3812395 A AU 3812395A
Authority
AU
Australia
Prior art keywords
cell ablation
inducible cell
inducible
ablation
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38123/95A
Inventor
John Clark
Thomas Connors
Barry Gusterson
Richard Knox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agricultural and Food Research Council
Cancer Research Campaign Technology Ltd
Original Assignee
Agricultural and Food Research Council
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural and Food Research Council, Cancer Research Campaign Technology Ltd filed Critical Agricultural and Food Research Council
Publication of AU3812395A publication Critical patent/AU3812395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027New breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01284S-(hydroxymethyl)glutathione dehydrogenase (1.1.1.284), i.e. nitroreductase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/30Animal model comprising expression system for selective cell killing, e.g. toxins, enzyme dependent prodrug therapy using ganciclovir
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU38123/95A 1994-11-04 1995-11-06 Inducible cell ablation Abandoned AU3812395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9422264 1994-11-04
GB9422264A GB9422264D0 (en) 1994-11-04 1994-11-04 Inducible cell ablation
PCT/GB1995/002596 WO1996014420A1 (en) 1994-11-04 1995-11-06 Inducible cell ablation

Publications (1)

Publication Number Publication Date
AU3812395A true AU3812395A (en) 1996-05-31

Family

ID=10763890

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38123/95A Abandoned AU3812395A (en) 1994-11-04 1995-11-06 Inducible cell ablation

Country Status (3)

Country Link
AU (1) AU3812395A (en)
GB (1) GB9422264D0 (en)
WO (1) WO1996014420A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576813B2 (en) 1997-01-31 2003-06-10 Dnavec Research Inc. Knockout animals
GB9705744D0 (en) * 1997-03-20 1997-05-07 Davies Alison M Methods for selecting cells and their uses
AU7334398A (en) * 1997-04-03 1998-10-22 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Transgenic animal with controllable hyperproliferation and inflammation phenotype in the skin
US10357577B2 (en) 2010-07-16 2019-07-23 Auckland Uniservices Limited Bacterial nitroreductase enzymes and methods relating thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008288A1 (en) * 1991-10-23 1993-04-29 Cancer Research Campaign Technology Limited Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
WO1994021118A1 (en) * 1993-03-24 1994-09-29 The Uab Research Foundation Gene-therapy composition and method for treating carcinomas
GB9323008D0 (en) * 1993-11-05 1994-01-05 Connors Thomas Improvements relating to cancer therapy

Also Published As

Publication number Publication date
WO1996014420A1 (en) 1996-05-17
GB9422264D0 (en) 1994-12-21

Similar Documents

Publication Publication Date Title
AU2380297A (en) Electrode arrangement
AU2023995A (en) Electrochemical cell
AU3991995A (en) Insulated implement
AU2651897A (en) Electrode for welding
AUPM842194A0 (en) Propulsion unit
AU4321797A (en) Eyedrops
AU1761395A (en) Hull configuration
AU1805597A (en) Electrochemical cell
AU2632795A (en) Knife
AU1614595A (en) Battery
AU1048397A (en) Battery assembly
AU1531695A (en) Electro-chemical cell
AU2634695A (en) Hull-related arrangement
AU2065797A (en) Multi-use cutter
AU3812395A (en) Inducible cell ablation
AU2799795A (en) Catamaran
AU5887098A (en) Rudder
AU3183695A (en) Membrane
AU1877697A (en) Electrochemical cell
AU5308998A (en) Dispersoid-reinforced electrode
AU3842095A (en) Reporter cell line
AU9649198A (en) Enclosed cell
AU1790797A (en) Substituted 2-phenylpyridines
AU4713496A (en) Reporter cell line
AU4129797A (en) Cutters